A detailed history of Galvin, Gaustad & Stein, LLC transactions in Mckesson Corp stock. As of the latest transaction made, Galvin, Gaustad & Stein, LLC holds 1,052 shares of MCK stock, worth $546,861. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,052
Previous 1,151 8.6%
Holding current value
$546,861
Previous $617,000 0.49%
% of portfolio
0.06%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$518.81 - $607.81 $51,362 - $60,173
-99 Reduced 8.6%
1,052 $614,000
Q1 2024

Apr 15, 2024

SELL
$473.42 - $539.26 $2,367 - $2,696
-5 Reduced 0.43%
1,151 $617,000
Q4 2023

Jan 11, 2024

SELL
$437.42 - $470.64 $10,498 - $11,295
-24 Reduced 2.03%
1,156 $535,000
Q3 2023

Oct 18, 2023

SELL
$402.4 - $446.42 $16,900 - $18,749
-42 Reduced 3.44%
1,180 $513,000
Q4 2022

Feb 13, 2023

SELL
$346.68 - $397.58 $67,602 - $77,528
-195 Reduced 13.76%
1,222 $458,000
Q3 2022

Oct 26, 2022

SELL
$321.25 - $373.84 $19,275 - $22,430
-60 Reduced 4.06%
1,417 $482,000
Q2 2022

Jul 22, 2022

SELL
$300.57 - $336.42 $130,146 - $145,669
-433 Reduced 22.67%
1,477 $482,000
Q1 2022

Apr 27, 2022

SELL
$244.61 - $310.48 $1.21 Million - $1.53 Million
-4,932 Reduced 72.08%
1,910 $585,000
Q4 2021

Jan 31, 2022

SELL
$198.21 - $248.9 $1.73 Million - $2.17 Million
-8,726 Reduced 56.05%
6,842 $1.7 Million
Q3 2021

Oct 29, 2021

SELL
$188.42 - $208.66 $20,914 - $23,161
-111 Reduced 0.71%
15,568 $3.1 Million
Q2 2021

Jul 29, 2021

BUY
$184.89 - $202.68 $367,561 - $402,927
1,988 Added 14.52%
15,679 $3 Million
Q1 2021

Apr 19, 2021

BUY
$169.52 - $196.53 $49,838 - $57,779
294 Added 2.19%
13,691 $2.67 Million
Q4 2020

Feb 04, 2021

BUY
$143.79 - $183.66 $1.93 Million - $2.46 Million
13,397 New
13,397 $2.33 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $74.7B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Galvin, Gaustad & Stein, LLC Portfolio

Follow Galvin, Gaustad & Stein, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Galvin, Gaustad & Stein, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Galvin, Gaustad & Stein, LLC with notifications on news.